Keros Therapeutics
KROS
KROS
80 hedge funds and large institutions have $599M invested in Keros Therapeutics in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 38 increasing their positions, 17 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
32% less capital invested
Capital invested by funds: $887M → $599M (-$287M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
80
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$24.1M | |
| 2 | +$7.64M | |
| 3 | +$7.62M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$5.88M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$5.71M |
Top Sellers
| 1 | -$85.1M | |
| 2 | -$12.1M | |
| 3 | -$6.65M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$4.92M |
| 5 |
VA
VR Adviser
New York
|
-$4.25M |